GEM Premier 5000 PAK BG/ISE/GL/COOX 300 TEST 00055430010Recalls & reported problems
Instrumentation Laboratory Company · GEM Premier 5000 PAK pH, pCO2, pO2, Na+, K+, Cl-, Ca++, Glucose, Lactate, Hct, tHb, O2Hb, COHb, MetHb, HHb, sO2 300 Test 31 Days · Class 2
Data updated Oct 18, 2026 from official FDA records · Editorial policy
2 open recalls name this device. See the recall details and contact the manufacturer or your healthcare provider.
- Adverse event reports
- 3
- Deaths reported
- 3
- Injuries reported
- 0
- Recalls naming it
- 2
Summary
The FDA's MAUDE database contains 3 adverse event reports that list this exact device (DI 08426950807759), received between Aug 13, 2026 and Sep 25, 2026 — classified as 3 deaths.
2 FDA recall records name this device's identifier, 2 still open.
23 other recalls cover devices cleared under the same FDA submission (K160225, K160402, K160415, K173403, K203790); they may or may not involve this specific model.
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.
Reports received per month
Recalls naming this device
- May 21, 2026Class IIOpen, Classified
The active ingredient concentration in the lysing bag solution of specific GEM Premier 5000 lots did not meet established manufacturing specifications. The malfunction could result in delayed recognition and management of Co-Oximetry and total bilirubin abnormalities and their sequelae.
Z-2900-2026 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗
- Jan 20, 2026Class IIOpen, Classified
Confirmed customer complaints indicating that GEM PAKs (cartridges) for the GEM Premier 5000 may experience an increased incidence of Process Control Solution Not Detected (PCSND) errors during warm-up, including consecutive occurrences, resulting in GEM PAK ejection and requiring insertion of a new GEM PAK. iQM2 is an active quality process control program designed to provide continuous monitoring of the entire testing process. Thus, if a GEM PAK completes AutoPAK Validation following warm-up, it may remain in use. Consecutive GEM PAK ejections during warm-up may prolong turnaround times, potentially delaying results. In such cases, patient management may require reassessment once results are available. While many GEM PAKs continue to perform as intended, consecutive ejections may increase the likelihood of operational disruption, highlighting the importance of advance planning where feasible to help minimize impact.
Z-1539-2026 · Root cause: Nonconforming Material/Component · Recall details · FDA record ↗
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem3
Patient problems
- Insufficient Information3
Recent adverse event reports
The 3 most recent of 3 reports, in the reporter's own words as published by the FDA.
DeathSep 25, 2026Adverse Event Without Identified Device or Use Problem
On (b)(6) 2026, the customer reported receiving incalculable results on a GEM 5000 analyzer and expressed concern that it was unclear whether the reported result was due to failed iQM2 quality checks or analyte values falling outside the analyzer's reportable range. The customer stated that this lack of clarity could impact clinical interpretation and decision-making. Due to uncertainty regarding the meaning of the result, the sample was repeated on a second analyzer, which reportedly produced similar findings. The customer requested clarification regarding the analyzer's reporting logic, specifically when results are displayed with less-than or greater-than reportable range indicators ("<" or ">") versus being reported as "incalculable."To further assess the patient, the customer performed a finger-stick glucose test, which reportedly indicated a glucose value below the reportable range. Based on this result, clinical intervention was initiated. Approximately 20 minutes later, a repeat blood gas sample was analyzed. The customer reported that the patient subsequently expired.The customer expressed concern that the patient's extremely low glucose concentration may have been reporte
Patient problems: Insufficient Information
MAUDE report 50898447 ↗DeathSep 25, 2026Adverse Event Without Identified Device or Use Problem
On (b)(6) 2026, the customer reported receiving incalculable results on a GEM 5000 analyzer and expressed concern that it was unclear whether the reported result was due to failed iQM2 quality checks or analyte values falling outside the analyzer's reportable range. The customer stated that this lack of clarity could impact clinical interpretation and decision-making. Due to uncertainty regarding the meaning of the result, the sample was repeated on a second analyzer, which reportedly produced similar findings. The customer requested clarification regarding the analyzer's reporting logic, specifically when results are displayed with less-than or greater-than reportable range indicators ("<" or ">") versus being reported as "incalculable."To further assess the patient, the customer performed a finger-stick glucose test, which reportedly indicated a glucose value below the reportable range. Based on this result, clinical intervention was initiated. Approximately 20 minutes later, a repeat blood gas sample was analyzed. The customer reported that the patient subsequently expired.The customer expressed concern that the patient's extremely low glucose concentration may have been reporte
Patient problems: Insufficient Information
MAUDE report 50898442 ↗DeathAug 13, 2026Adverse Event Without Identified Device or Use Problem
On (b)(6) 2026, the customer reported a delay in obtaining lactate testing results on a GEM 5000 analyzer located in the he Emergency Department. The customer stated that a patient death had occured follwoing a delay in obtaining lactate results, as lactate could not be measured in the ER and testing had to be delayed until the patient reached the ICU.
Patient problems: Insufficient Information
MAUDE report 50236251 ↗
Recalls under the same FDA submission
These recalls involve devices cleared under K160225, K160402, K160415, K173403, K203790. One submission often covers many models, so check the product and lot details in each record.
- Z-2824-2026 · May 8, 2026 · Open, ClassifiedBrand Name: GEM Premier 5000 Product Name: GEM Premier 5000 Model/Catalog Number: 00024019255 Product Description: The GEM Premier 5000 system provides fast, accurate, quantitative
- Z-2825-2026 · May 8, 2026 · Open, ClassifiedBrand Name: GEM Premier 5000 Product Name: GEM Premier 5000 Model/Catalog Number: 00024019255 Product Description: The GEM Premier 5000 system provides fast, accurate, quantitative
- Z-2823-2026 · May 8, 2026 · Open, ClassifiedBrand Name: GEM Premier 5000 Product Name: GEM Premier 5000 Model/Catalog Number: 00024019255 Product Description: The GEM Premier 5000 system provides fast, accurate, quantitative
- Z-2826-2026 · May 8, 2026 · Open, ClassifiedBrand Name: GEM Premier 5000 Product Name: GEM Premier 5000 Model/Catalog Number: 00024019255 Product Description: The GEM Premier 5000 system provides fast, accurate, quantitative
- Z-2821-2026 · May 8, 2026 · Open, ClassifiedBrand Name: GEM Premier 5000 Product Name: GEM Premier 5000 Model/Catalog Number: 00024019255 Intelligent Quality Management 2 (iQM2) is used as the quality control and assessment
- Z-1525-2026 · Jan 20, 2026 · Open, ClassifiedGEM Premier 5000 PAK; Part No. 00055360008.
- Z-1531-2026 · Jan 20, 2026 · Open, ClassifiedGEM Premier 5000 PAK; Part No. 00055407511.
- Z-1541-2026 · Jan 20, 2026 · Open, ClassifiedGEM Premier 5000; Part No. 00055445004.
- Z-1542-2026 · Jan 20, 2026 · Open, ClassifiedGEM Premier 5000; Part No. 00055445008.
- Z-1533-2026 · Jan 20, 2026 · Open, ClassifiedGEM Premier 5000; Part No. 00055415005.
- Z-1540-2026 · Jan 20, 2026 · Open, ClassifiedGEM Premier 5000; Part No. 00055430011.
- Z-1536-2026 · Jan 20, 2026 · Open, ClassifiedGEM Premier 5000; Part No: 00055415011.
- Z-1527-2026 · Jan 20, 2026 · Open, ClassifiedGEM Premier 5000 PAK; Part No. 00055360011.
- Z-1524-2026 · Jan 20, 2026 · Open, ClassifiedGEM Premier 5000 PAK, Part No. 00055360004.
- Z-1528-2026 · Jan 20, 2026 · Open, ClassifiedGEM Premier 5000 PAK; Part No. 00055407504.
…and 8 more.
Other ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH devices
- GEM Premier 5000 00024019255Instrumentation Laboratory Company · Electrode Measurement, Blood-Gases (Pco2, Po2) And Blood Ph5 recalls5 deaths7 reports
- ABL800 FLEX 393-800Radiometer Medical ApS · ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH2 recalls81 reports
- ABL90 FLEX Analyzer 393-090Radiometer Medical ApS · ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH1 recall112 reports
- i-STAT 03P88-25Abbott Point Of Care Inc. · ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH105 reports
- GEM Premier 5000 PAK BG/ISE/GL/COOX 450 TEST 00055445010Instrumentation Laboratory Company · ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH2 recalls2 reports
- GEM Premier 5000 PAK BG/ISE/GL/COOX 150 TEST 00055415010Instrumentation Laboratory Company · ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH2 recalls0 reports
- GEM Premier 5000 PAK BG/ISE/GL/COOX/TBILI 450 TEST 00055445011Instrumentation Laboratory Company · ELECTRODE MEASUREMENT, BLOOD-GASES (PCO2, PO2) AND BLOOD PH2 recalls0 reports
- Stat Profile Prime PlusNova Biomedical Corporation · Electrode measurement, blood-gases (pco2, po2) and blood ph1 recall1 death50 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026 · each recall links to the FDA recall notice
- Page last rebuilt: Oct 18, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page